DoD Prostate Cancer Population Science Impact Award

The summary for the DoD Prostate Cancer Population Science Impact Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Prostate Cancer Population Science Impact Award: The PCRP Population Science Impact Award mechanism was first offered as the Population-Based Idea Development Award in FY09 and the Population-Based Research Award in FY10 and FY11. Since then, 62 applications have been received, and 4 have been recommended for funding. The Population Science Impact Award mechanism supports high-impact, population science approaches to prostate cancer research. Applications should clearly demonstrate the potential of the study to contribute significantly to the elimination of death from prostate cancer and/or enhancing the well-being of men experiencing the impact of the disease. As such, studies should address one of the PCRP overarching challenges, or, alternatively, justify the study as addressing another critical area in prostate cancer research. In addition, studies are expected to address one or more of the PCRP focus areas; for the Population Science Impact Award, projects focused on the following are particularly encouraged: genetics/genomics and biomarkers, especially those relevant to the early detection of aggressive disease, prognosis, and treatment response; survivorship and palliative care; and health disparity. The overall goal of this award is to generate data and/or tools that can only be achieved from the perspective of systematic studies focused on specific populations of individuals, rather than specific individuals. Such studies will be built upon the logic, concepts, and methods of one or more population sciences including but not limited to: • Epidemiology • Surveillance • Health services research • Outcomes research • Behavioral science • Social science • Dissemination research The outcomes for research supported through this award mechanism will have the potential for substantial impact for men with or at risk for prostate cancer within, for example, epidemiologic cohorts, defined communities, or health systems. Applications may propose retrospective, prospective, case control, cohort, or other population science study designs (including the use of biospecimens and data from established retrospective databases), provided that the study population is of sufficient size to provide appropriate statistical power. The study should address a well-developed hypothesis that is conceptually sound and specific for prostate cancer. The epidemiologic and/or biostatistical expertise of the study team should be clearly described and evident in the study plan. Applicants are expected to provide documentation demonstrating access to, and ability to recruit, the appropriate population(s), patient samples, and/or datasets in numbers sufficient to achieve robust statistical significance. Research involving human subject use is permitted under this funding opportunity; however, clinical trials will be supported only if they are determined to be no greater than minimal risk by the local Institutional Review Board (IRB) of record and the U.S. Army Medical Research and Materiel Command (USAMRMC) Office of Research Protections (ORP), Human Research Protection Office (HRPO). For example, a behavioral clinical trial with a prospective accrual of patients where a behavioral intervention (i.e., cohort or case-controlled study) has been designed to determine the outcome (testing instrument, study tool, hazard, etc.) with respect to exploratory information, safety, or effectiveness may be allowed if it is no greater than minimal risk as determined by the local IRB of record and HRPO. Clinical trials involving prospective accrual of patients to test a device, drug, biologic, or surgical procedure for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy will not be supported by this award mechanism. Correlative studies associated with a clinical trial testing a device, drug, biologic, or surgical procedure are permitted if it is determined to be no greater than minimal risk by the local IRB of record and HRPO. A correlative study is defined as a prospective or retrospective collection of human anatomical substances (e.g., tissue, blood, nail clippings, bone marrow, behavioral documentation, other) to be used in research to answer a question regarding the disease, injury or condition, and/or intervention. It does not include the direct assessment of the outcome of any intervention for the prevention, diagnosis, treatment, or evaluation of the quality of life of the patient. Human subject research qualifying as greater than minimal risk will not be supported by this award mechanism.
Federal Grant Title: DoD Prostate Cancer Population Science Impact Award
Federal Agency Name: Dept of the Army USAMRAA
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: W81XWH-14-PCRP-PSIA
Type of Funding: Cooperative Agreement, Grant
CFDA Numbers: 12.420
CFDA Descriptions: Military Medical Research and Development
Current Application Deadline: Oct 29, 2014
Original Application Deadline: Oct 29, 2014
Posted Date: May 30, 2014
Creation Date: May 30, 2014
Archive Date: Nov 28, 2014
Total Program Funding: $3,600,000
Maximum Federal Grant Award: $0
Minimum Federal Grant Award: $0
Expected Number of Awards: 3
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
CDMRP Help Desk 301-682-5507
CDMRP Help Desk

Dept. of the Army -- USAMRAA 301-619-7144
Similar Government Grants
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research a...
DoD Kidney Cancer, Clinical Consortium Award
DOD Toxic Exposures, Translational Research Award
DOD Toxic Exposures, Investigator-Initiated Research Award
DOD Toxic Exposures, Clinical Trial Award
FY2006 Deployed War Fighter Protection Research Program
Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Dept of the Army USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research a...
DoD Kidney Cancer, Clinical Consortium Award
DOD Toxic Exposures, Translational Research Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com